» Articles » PMID: 29019812

Venous Thromboembolism After Adult Lung Transplantation: A Frequent Event Associated With Lower Survival

Overview
Journal Transplantation
Specialty General Surgery
Date 2017 Oct 12
PMID 29019812
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The incidence of venous thromboembolism (VTE) after lung transplantation (LTX) varies significantly across studies. Two studies have suggested that these thrombotic events are associated with a lower posttransplant survival. Herein, we sought to determine the incidence, predictors, and impact of VTE on survival after LTX at a quaternary referral center.

Methods: This was a large cohort study of LTX recipients. Key outcome parameters were time to VTE after transplant and survival. Deep vein thrombosis (DVT) diagnosis required a positive ultrasound. Pulmonary embolism diagnosis required either a positive chest computed tomography angiogram or a high-probability ventilation/perfusion scan.

Results: The overall incidence of VTE among 701 LTX recipients was 43.8%, of which 97.7% were DVT episodes, of which 71.3% were in the upper extremities. Predictors of VTE were prior history of DVT (hazard ratio [HR], 2.82; 95% confidence interval [CI], 1.49-5.37), days in intensive care (HR, 1.01; 95% CI, 1.01-1.02), and the use of extracorporeal membrane oxygenation (HR, 2.22; 95% CI, 1.43-3.45). Importantly, VTE predicted a lower posttransplant survival (HR, 1.70; 95% CI, 1.28-2.26), when occurring within or after the first 30 days. The location of the DVT, either upper extremity or below the knee, also predicted a poor survival.

Conclusions: VTE was frequent in LTX recipients and predicted a poor survival even when located in the upper extremities or below the knee. These data suggest that aggressive VTE screening/treatment protocols be implemented in post-LTX population.

Citing Articles

Acute pulmonary embolism treatment in lung transplant recipients: mechanical thrombectomy and catheter directed thrombolysis.

Arar A, Rice S, Alnablsi M, Pillai A, Benjamin J, Quadri R CVIR Endovasc. 2025; 8(1):19.

PMID: 40067640 PMC: 11896909. DOI: 10.1186/s42155-024-00512-z.


Survival in Patients With Evidence of Pulmonary Thromboembolism on Ventilation-Perfusion SPECT 12 Weeks After Double Lung Transplantation: A Retrospective Cohort Study.

Mohammad M, Kristensen A, Hartmann J, Wareham N, Buttar S, Greve A Clin Transplant. 2025; 39(2):e70103.

PMID: 39927856 PMC: 11809467. DOI: 10.1111/ctr.70103.


Assessing Venous Thrombotic Risks in Extracorporeal Membrane Oxygenation-Supported Patients: A Systematic Review and Meta-Analysis.

Zhu Y, Lan M, Liang J, Cai L, Guo L, Gu P Clin Appl Thromb Hemost. 2024; 30:10760296241279293.

PMID: 39246243 PMC: 11388296. DOI: 10.1177/10760296241279293.


assessment of the risk of ABCB1-mediated drug-drug interaction between rivaroxaban and tacrolimus in human embryonic kidney 293 recombinant cell lines.

Mahieu G, Sennesael A, Pochet L, Haufroid V, Van Bambeke F, Spinewine A Res Pract Thromb Haemost. 2024; 8(5):102521.

PMID: 39228433 PMC: 11369460. DOI: 10.1016/j.rpth.2024.102521.


The impact of early perioperative heparin-free anticoagulation for extracorporeal membrane oxygenation on bleeding and thrombotic events in lung transplantation: a retrospective cohort study.

Qi Z, Gu S, Yu X, Zhang Z, Cui X, Li C Ther Adv Respir Dis. 2024; 18:17534666241273012.

PMID: 39161257 PMC: 11334139. DOI: 10.1177/17534666241273012.


References
1.
Yusen R, Edwards L, Kucheryavaya A, Benden C, Dipchand A, Goldfarb S . The Registry of the International Society for Heart and Lung Transplantation: Thirty-second Official Adult Lung and Heart-Lung Transplantation Report--2015; Focus Theme: Early Graft Failure. J Heart Lung Transplant. 2015; 34(10):1264-77. DOI: 10.1016/j.healun.2015.08.014. View

2.
. Unilateral lung transplantation for pulmonary fibrosis. N Engl J Med. 1986; 314(18):1140-5. DOI: 10.1056/NEJM198605013141802. View

3.
Izbicki G, Bairey O, Shitrit D, Lahav J, Kramer M . Increased thromboembolic events after lung transplantation. Chest. 2006; 129(2):412-416. DOI: 10.1378/chest.129.2.412. View

4.
Hanson S, Punzalan R, Christensen M, Ghanayem N, Kuhn E, Havens P . Incidence and risk factors for venous thromboembolism in critically ill children with cardiac disease. Pediatr Cardiol. 2011; 33(1):103-8. DOI: 10.1007/s00246-011-0098-2. View

5.
Kijiyama N, Ueno H, Sugimoto I, Sasaguri Y, Yatera K, Kido M . Intratracheal gene transfer of tissue factor pathway inhibitor attenuates pulmonary fibrosis. Biochem Biophys Res Commun. 2005; 339(4):1113-9. DOI: 10.1016/j.bbrc.2005.11.127. View